Abstract
Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy in adulthood. Temporal lobe plays a central role in the regulation of cardio-autonomic functions (CAF) which can be also influenced by several anti-seizure therapies. The spectral analysis of the Heart Rate Variability (HRV) represents a useful tool for the evaluation of CAF. The aim of this study is to assess, using the spectral analysis of HRV, new anti-seizure medication (ASMs) - Perampanel (PER), Lacosamide (LCS), Eslicarbazepine (ECB) and Brivaracetam (BRV) - effects on CAF in patients with TLE.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
